Global Vaginal Anti Infectives Market Growth 2022-2028
The report requires updating with new data and is sent in 48 hours after order is placed.
Vaginal anti-infectives are the type of agents that are used for the killing or supressing the infection of vagina caused by numerous bacteria, virus, fungi or micro-organism. These bacteria and others invade the host by means of its replication or releasing several toxins into the host. 'Yeast' infections, tyrichomoniasis vaginitis, bacterial vaginosis, chlamydia vaginitis, and viral vaginitis are the major forms of vaginitis. About one third women all over the world experience indications of vaginitis at some point in their lifetime. Women are highly prone to vaginitis during the reproductive age; a change in the balance of bacteria and yeast present in vagina can lead to vaginitis.
The global market for Vaginal Anti Infectives is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Vaginal Anti Infectives market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Vaginal Anti Infectives market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Vaginal Anti Infectives market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Vaginal Anti Infectives market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Vaginal Anti Infectives players cover Pfizer Inc, Mylan N.V, Novartis AG, Hikma Pharmaceuticals plc and Aurobindo Pharma, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Vaginal Anti Infectives market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Vaginal Anti Infectives market, with both quantitative and qualitative data, to help readers understand how the Vaginal Anti Infectives market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions and volume in K Units.
Market Segmentation:
The study segments the Vaginal Anti Infectives market and forecasts the market size by Type (Oral and Ointment,), by Application (Bacterial Vaginitis, Trichomonal Vaginitis and Candida Vaginitis,), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
Chapter 1: Scope of Vaginal Anti Infectives, Research Methodology, etc.
Chapter 2: Executive Summary, global Vaginal Anti Infectives market size (sales and revenue) and CAGR, Vaginal Anti Infectives market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Vaginal Anti Infectives sales, revenue, average price, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Vaginal Anti Infectives sales and revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, sales segment by country, by type, and type.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Vaginal Anti Infectives market size forecast by region, by country, by type, and application.
Chapter 13: Comprehensive company profiles of the leading players, including Pfizer Inc, Mylan N.V, Novartis AG, Hikma Pharmaceuticals plc, Aurobindo Pharma, AbbVie Inc, Melinta Therapeutics, Inc, Bristol-Myers Squibb Company and GSK plc, etc.
Chapter 14: Research Findings and Conclusion
Vaginal anti-infectives are the type of agents that are used for the killing or supressing the infection of vagina caused by numerous bacteria, virus, fungi or micro-organism. These bacteria and others invade the host by means of its replication or releasing several toxins into the host. 'Yeast' infections, tyrichomoniasis vaginitis, bacterial vaginosis, chlamydia vaginitis, and viral vaginitis are the major forms of vaginitis. About one third women all over the world experience indications of vaginitis at some point in their lifetime. Women are highly prone to vaginitis during the reproductive age; a change in the balance of bacteria and yeast present in vagina can lead to vaginitis.
The global market for Vaginal Anti Infectives is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Vaginal Anti Infectives market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Vaginal Anti Infectives market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Vaginal Anti Infectives market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Vaginal Anti Infectives market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Vaginal Anti Infectives players cover Pfizer Inc, Mylan N.V, Novartis AG, Hikma Pharmaceuticals plc and Aurobindo Pharma, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Vaginal Anti Infectives market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Vaginal Anti Infectives market, with both quantitative and qualitative data, to help readers understand how the Vaginal Anti Infectives market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions and volume in K Units.
Market Segmentation:
The study segments the Vaginal Anti Infectives market and forecasts the market size by Type (Oral and Ointment,), by Application (Bacterial Vaginitis, Trichomonal Vaginitis and Candida Vaginitis,), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
- Oral
- Ointment
- Bacterial Vaginitis
- Trichomonal Vaginitis
- Candida Vaginitis
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Pfizer Inc
- Mylan N.V
- Novartis AG
- Hikma Pharmaceuticals plc
- Aurobindo Pharma
- AbbVie Inc
- Melinta Therapeutics, Inc
- Bristol-Myers Squibb Company
- GSK plc
- Bayer AG
- Lupin
- Perrigo Company plc
Chapter 1: Scope of Vaginal Anti Infectives, Research Methodology, etc.
Chapter 2: Executive Summary, global Vaginal Anti Infectives market size (sales and revenue) and CAGR, Vaginal Anti Infectives market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Vaginal Anti Infectives sales, revenue, average price, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Vaginal Anti Infectives sales and revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, sales segment by country, by type, and type.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Vaginal Anti Infectives market size forecast by region, by country, by type, and application.
Chapter 13: Comprehensive company profiles of the leading players, including Pfizer Inc, Mylan N.V, Novartis AG, Hikma Pharmaceuticals plc, Aurobindo Pharma, AbbVie Inc, Melinta Therapeutics, Inc, Bristol-Myers Squibb Company and GSK plc, etc.
Chapter 14: Research Findings and Conclusion
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Vaginal Anti Infectives Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Vaginal Anti Infectives by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Vaginal Anti Infectives by Country/Region, 2017, 2022 & 2028
2.2 Vaginal Anti Infectives Segment by Type
2.2.1 Oral
2.2.2 Ointment
2.3 Vaginal Anti Infectives Sales by Type
2.3.1 Global Vaginal Anti Infectives Sales Market Share by Type (2017-2022)
2.3.2 Global Vaginal Anti Infectives Revenue and Market Share by Type (2017-2022)
2.3.3 Global Vaginal Anti Infectives Sale Price by Type (2017-2022)
2.4 Vaginal Anti Infectives Segment by Application
2.4.1 Bacterial Vaginitis
2.4.2 Trichomonal Vaginitis
2.4.3 Candida Vaginitis
2.5 Vaginal Anti Infectives Sales by Application
2.5.1 Global Vaginal Anti Infectives Sale Market Share by Application (2017-2022)
2.5.2 Global Vaginal Anti Infectives Revenue and Market Share by Application (2017-2022)
2.5.3 Global Vaginal Anti Infectives Sale Price by Application (2017-2022)
3 GLOBAL VAGINAL ANTI INFECTIVES BY COMPANY
3.1 Global Vaginal Anti Infectives Breakdown Data by Company
3.1.1 Global Vaginal Anti Infectives Annual Sales by Company (2020-2022)
3.1.2 Global Vaginal Anti Infectives Sales Market Share by Company (2020-2022)
3.2 Global Vaginal Anti Infectives Annual Revenue by Company (2020-2022)
3.2.1 Global Vaginal Anti Infectives Revenue by Company (2020-2022)
3.2.2 Global Vaginal Anti Infectives Revenue Market Share by Company (2020-2022)
3.3 Global Vaginal Anti Infectives Sale Price by Company
3.4 Key Manufacturers Vaginal Anti Infectives Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Vaginal Anti Infectives Product Location Distribution
3.4.2 Players Vaginal Anti Infectives Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR VAGINAL ANTI INFECTIVES BY GEOGRAPHIC REGION
4.1 World Historic Vaginal Anti Infectives Market Size by Geographic Region (2017-2022)
4.1.1 Global Vaginal Anti Infectives Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Vaginal Anti Infectives Annual Revenue by Geographic Region
4.2 World Historic Vaginal Anti Infectives Market Size by Country/Region (2017-2022)
4.2.1 Global Vaginal Anti Infectives Annual Sales by Country/Region (2017-2022)
4.2.2 Global Vaginal Anti Infectives Annual Revenue by Country/Region
4.3 Americas Vaginal Anti Infectives Sales Growth
4.4 APAC Vaginal Anti Infectives Sales Growth
4.5 Europe Vaginal Anti Infectives Sales Growth
4.6 Middle East & Africa Vaginal Anti Infectives Sales Growth
5 AMERICAS
5.1 Americas Vaginal Anti Infectives Sales by Country
5.1.1 Americas Vaginal Anti Infectives Sales by Country (2017-2022)
5.1.2 Americas Vaginal Anti Infectives Revenue by Country (2017-2022)
5.2 Americas Vaginal Anti Infectives Sales by Type
5.3 Americas Vaginal Anti Infectives Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Vaginal Anti Infectives Sales by Region
6.1.1 APAC Vaginal Anti Infectives Sales by Region (2017-2022)
6.1.2 APAC Vaginal Anti Infectives Revenue by Region (2017-2022)
6.2 APAC Vaginal Anti Infectives Sales by Type
6.3 APAC Vaginal Anti Infectives Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Vaginal Anti Infectives by Country
7.1.1 Europe Vaginal Anti Infectives Sales by Country (2017-2022)
7.1.2 Europe Vaginal Anti Infectives Revenue by Country (2017-2022)
7.2 Europe Vaginal Anti Infectives Sales by Type
7.3 Europe Vaginal Anti Infectives Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Vaginal Anti Infectives by Country
8.1.1 Middle East & Africa Vaginal Anti Infectives Sales by Country (2017-2022)
8.1.2 Middle East & Africa Vaginal Anti Infectives Revenue by Country (2017-2022)
8.2 Middle East & Africa Vaginal Anti Infectives Sales by Type
8.3 Middle East & Africa Vaginal Anti Infectives Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Vaginal Anti Infectives
10.3 Manufacturing Process Analysis of Vaginal Anti Infectives
10.4 Industry Chain Structure of Vaginal Anti Infectives
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Vaginal Anti Infectives Distributors
11.3 Vaginal Anti Infectives Customer
12 WORLD FORECAST REVIEW FOR VAGINAL ANTI INFECTIVES BY GEOGRAPHIC REGION
12.1 Global Vaginal Anti Infectives Market Size Forecast by Region
12.1.1 Global Vaginal Anti Infectives Forecast by Region (2023-2028)
12.1.2 Global Vaginal Anti Infectives Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Vaginal Anti Infectives Forecast by Type
12.7 Global Vaginal Anti Infectives Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Pfizer Inc
13.1.1 Pfizer Inc Company Information
13.1.2 Pfizer Inc Vaginal Anti Infectives Product Offered
13.1.3 Pfizer Inc Vaginal Anti Infectives Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Pfizer Inc Main Business Overview
13.1.5 Pfizer Inc Latest Developments
13.2 Mylan N.V
13.2.1 Mylan N.V Company Information
13.2.2 Mylan N.V Vaginal Anti Infectives Product Offered
13.2.3 Mylan N.V Vaginal Anti Infectives Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Mylan N.V Main Business Overview
13.2.5 Mylan N.V Latest Developments
13.3 Novartis AG
13.3.1 Novartis AG Company Information
13.3.2 Novartis AG Vaginal Anti Infectives Product Offered
13.3.3 Novartis AG Vaginal Anti Infectives Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Novartis AG Main Business Overview
13.3.5 Novartis AG Latest Developments
13.4 Hikma Pharmaceuticals plc
13.4.1 Hikma Pharmaceuticals plc Company Information
13.4.2 Hikma Pharmaceuticals plc Vaginal Anti Infectives Product Offered
13.4.3 Hikma Pharmaceuticals plc Vaginal Anti Infectives Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Hikma Pharmaceuticals plc Main Business Overview
13.4.5 Hikma Pharmaceuticals plc Latest Developments
13.5 Aurobindo Pharma
13.5.1 Aurobindo Pharma Company Information
13.5.2 Aurobindo Pharma Vaginal Anti Infectives Product Offered
13.5.3 Aurobindo Pharma Vaginal Anti Infectives Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Aurobindo Pharma Main Business Overview
13.5.5 Aurobindo Pharma Latest Developments
13.6 AbbVie Inc
13.6.1 AbbVie Inc Company Information
13.6.2 AbbVie Inc Vaginal Anti Infectives Product Offered
13.6.3 AbbVie Inc Vaginal Anti Infectives Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 AbbVie Inc Main Business Overview
13.6.5 AbbVie Inc Latest Developments
13.7 Melinta Therapeutics, Inc
13.7.1 Melinta Therapeutics, Inc Company Information
13.7.2 Melinta Therapeutics, Inc Vaginal Anti Infectives Product Offered
13.7.3 Melinta Therapeutics, Inc Vaginal Anti Infectives Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Melinta Therapeutics, Inc Main Business Overview
13.7.5 Melinta Therapeutics, Inc Latest Developments
13.8 Bristol-Myers Squibb Company
13.8.1 Bristol-Myers Squibb Company Company Information
13.8.2 Bristol-Myers Squibb Company Vaginal Anti Infectives Product Offered
13.8.3 Bristol-Myers Squibb Company Vaginal Anti Infectives Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Bristol-Myers Squibb Company Main Business Overview
13.8.5 Bristol-Myers Squibb Company Latest Developments
13.9 GSK plc
13.9.1 GSK plc Company Information
13.9.2 GSK plc Vaginal Anti Infectives Product Offered
13.9.3 GSK plc Vaginal Anti Infectives Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 GSK plc Main Business Overview
13.9.5 GSK plc Latest Developments
13.10 Bayer AG
13.10.1 Bayer AG Company Information
13.10.2 Bayer AG Vaginal Anti Infectives Product Offered
13.10.3 Bayer AG Vaginal Anti Infectives Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Bayer AG Main Business Overview
13.10.5 Bayer AG Latest Developments
13.11 Lupin
13.11.1 Lupin Company Information
13.11.2 Lupin Vaginal Anti Infectives Product Offered
13.11.3 Lupin Vaginal Anti Infectives Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Lupin Main Business Overview
13.11.5 Lupin Latest Developments
13.12 Perrigo Company plc
13.12.1 Perrigo Company plc Company Information
13.12.2 Perrigo Company plc Vaginal Anti Infectives Product Offered
13.12.3 Perrigo Company plc Vaginal Anti Infectives Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 Perrigo Company plc Main Business Overview
13.12.5 Perrigo Company plc Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Vaginal Anti Infectives Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Vaginal Anti Infectives by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Vaginal Anti Infectives by Country/Region, 2017, 2022 & 2028
2.2 Vaginal Anti Infectives Segment by Type
2.2.1 Oral
2.2.2 Ointment
2.3 Vaginal Anti Infectives Sales by Type
2.3.1 Global Vaginal Anti Infectives Sales Market Share by Type (2017-2022)
2.3.2 Global Vaginal Anti Infectives Revenue and Market Share by Type (2017-2022)
2.3.3 Global Vaginal Anti Infectives Sale Price by Type (2017-2022)
2.4 Vaginal Anti Infectives Segment by Application
2.4.1 Bacterial Vaginitis
2.4.2 Trichomonal Vaginitis
2.4.3 Candida Vaginitis
2.5 Vaginal Anti Infectives Sales by Application
2.5.1 Global Vaginal Anti Infectives Sale Market Share by Application (2017-2022)
2.5.2 Global Vaginal Anti Infectives Revenue and Market Share by Application (2017-2022)
2.5.3 Global Vaginal Anti Infectives Sale Price by Application (2017-2022)
3 GLOBAL VAGINAL ANTI INFECTIVES BY COMPANY
3.1 Global Vaginal Anti Infectives Breakdown Data by Company
3.1.1 Global Vaginal Anti Infectives Annual Sales by Company (2020-2022)
3.1.2 Global Vaginal Anti Infectives Sales Market Share by Company (2020-2022)
3.2 Global Vaginal Anti Infectives Annual Revenue by Company (2020-2022)
3.2.1 Global Vaginal Anti Infectives Revenue by Company (2020-2022)
3.2.2 Global Vaginal Anti Infectives Revenue Market Share by Company (2020-2022)
3.3 Global Vaginal Anti Infectives Sale Price by Company
3.4 Key Manufacturers Vaginal Anti Infectives Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Vaginal Anti Infectives Product Location Distribution
3.4.2 Players Vaginal Anti Infectives Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR VAGINAL ANTI INFECTIVES BY GEOGRAPHIC REGION
4.1 World Historic Vaginal Anti Infectives Market Size by Geographic Region (2017-2022)
4.1.1 Global Vaginal Anti Infectives Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Vaginal Anti Infectives Annual Revenue by Geographic Region
4.2 World Historic Vaginal Anti Infectives Market Size by Country/Region (2017-2022)
4.2.1 Global Vaginal Anti Infectives Annual Sales by Country/Region (2017-2022)
4.2.2 Global Vaginal Anti Infectives Annual Revenue by Country/Region
4.3 Americas Vaginal Anti Infectives Sales Growth
4.4 APAC Vaginal Anti Infectives Sales Growth
4.5 Europe Vaginal Anti Infectives Sales Growth
4.6 Middle East & Africa Vaginal Anti Infectives Sales Growth
5 AMERICAS
5.1 Americas Vaginal Anti Infectives Sales by Country
5.1.1 Americas Vaginal Anti Infectives Sales by Country (2017-2022)
5.1.2 Americas Vaginal Anti Infectives Revenue by Country (2017-2022)
5.2 Americas Vaginal Anti Infectives Sales by Type
5.3 Americas Vaginal Anti Infectives Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Vaginal Anti Infectives Sales by Region
6.1.1 APAC Vaginal Anti Infectives Sales by Region (2017-2022)
6.1.2 APAC Vaginal Anti Infectives Revenue by Region (2017-2022)
6.2 APAC Vaginal Anti Infectives Sales by Type
6.3 APAC Vaginal Anti Infectives Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Vaginal Anti Infectives by Country
7.1.1 Europe Vaginal Anti Infectives Sales by Country (2017-2022)
7.1.2 Europe Vaginal Anti Infectives Revenue by Country (2017-2022)
7.2 Europe Vaginal Anti Infectives Sales by Type
7.3 Europe Vaginal Anti Infectives Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Vaginal Anti Infectives by Country
8.1.1 Middle East & Africa Vaginal Anti Infectives Sales by Country (2017-2022)
8.1.2 Middle East & Africa Vaginal Anti Infectives Revenue by Country (2017-2022)
8.2 Middle East & Africa Vaginal Anti Infectives Sales by Type
8.3 Middle East & Africa Vaginal Anti Infectives Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Vaginal Anti Infectives
10.3 Manufacturing Process Analysis of Vaginal Anti Infectives
10.4 Industry Chain Structure of Vaginal Anti Infectives
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Vaginal Anti Infectives Distributors
11.3 Vaginal Anti Infectives Customer
12 WORLD FORECAST REVIEW FOR VAGINAL ANTI INFECTIVES BY GEOGRAPHIC REGION
12.1 Global Vaginal Anti Infectives Market Size Forecast by Region
12.1.1 Global Vaginal Anti Infectives Forecast by Region (2023-2028)
12.1.2 Global Vaginal Anti Infectives Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Vaginal Anti Infectives Forecast by Type
12.7 Global Vaginal Anti Infectives Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Pfizer Inc
13.1.1 Pfizer Inc Company Information
13.1.2 Pfizer Inc Vaginal Anti Infectives Product Offered
13.1.3 Pfizer Inc Vaginal Anti Infectives Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Pfizer Inc Main Business Overview
13.1.5 Pfizer Inc Latest Developments
13.2 Mylan N.V
13.2.1 Mylan N.V Company Information
13.2.2 Mylan N.V Vaginal Anti Infectives Product Offered
13.2.3 Mylan N.V Vaginal Anti Infectives Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Mylan N.V Main Business Overview
13.2.5 Mylan N.V Latest Developments
13.3 Novartis AG
13.3.1 Novartis AG Company Information
13.3.2 Novartis AG Vaginal Anti Infectives Product Offered
13.3.3 Novartis AG Vaginal Anti Infectives Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Novartis AG Main Business Overview
13.3.5 Novartis AG Latest Developments
13.4 Hikma Pharmaceuticals plc
13.4.1 Hikma Pharmaceuticals plc Company Information
13.4.2 Hikma Pharmaceuticals plc Vaginal Anti Infectives Product Offered
13.4.3 Hikma Pharmaceuticals plc Vaginal Anti Infectives Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Hikma Pharmaceuticals plc Main Business Overview
13.4.5 Hikma Pharmaceuticals plc Latest Developments
13.5 Aurobindo Pharma
13.5.1 Aurobindo Pharma Company Information
13.5.2 Aurobindo Pharma Vaginal Anti Infectives Product Offered
13.5.3 Aurobindo Pharma Vaginal Anti Infectives Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Aurobindo Pharma Main Business Overview
13.5.5 Aurobindo Pharma Latest Developments
13.6 AbbVie Inc
13.6.1 AbbVie Inc Company Information
13.6.2 AbbVie Inc Vaginal Anti Infectives Product Offered
13.6.3 AbbVie Inc Vaginal Anti Infectives Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 AbbVie Inc Main Business Overview
13.6.5 AbbVie Inc Latest Developments
13.7 Melinta Therapeutics, Inc
13.7.1 Melinta Therapeutics, Inc Company Information
13.7.2 Melinta Therapeutics, Inc Vaginal Anti Infectives Product Offered
13.7.3 Melinta Therapeutics, Inc Vaginal Anti Infectives Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Melinta Therapeutics, Inc Main Business Overview
13.7.5 Melinta Therapeutics, Inc Latest Developments
13.8 Bristol-Myers Squibb Company
13.8.1 Bristol-Myers Squibb Company Company Information
13.8.2 Bristol-Myers Squibb Company Vaginal Anti Infectives Product Offered
13.8.3 Bristol-Myers Squibb Company Vaginal Anti Infectives Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Bristol-Myers Squibb Company Main Business Overview
13.8.5 Bristol-Myers Squibb Company Latest Developments
13.9 GSK plc
13.9.1 GSK plc Company Information
13.9.2 GSK plc Vaginal Anti Infectives Product Offered
13.9.3 GSK plc Vaginal Anti Infectives Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 GSK plc Main Business Overview
13.9.5 GSK plc Latest Developments
13.10 Bayer AG
13.10.1 Bayer AG Company Information
13.10.2 Bayer AG Vaginal Anti Infectives Product Offered
13.10.3 Bayer AG Vaginal Anti Infectives Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Bayer AG Main Business Overview
13.10.5 Bayer AG Latest Developments
13.11 Lupin
13.11.1 Lupin Company Information
13.11.2 Lupin Vaginal Anti Infectives Product Offered
13.11.3 Lupin Vaginal Anti Infectives Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Lupin Main Business Overview
13.11.5 Lupin Latest Developments
13.12 Perrigo Company plc
13.12.1 Perrigo Company plc Company Information
13.12.2 Perrigo Company plc Vaginal Anti Infectives Product Offered
13.12.3 Perrigo Company plc Vaginal Anti Infectives Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 Perrigo Company plc Main Business Overview
13.12.5 Perrigo Company plc Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Vaginal Anti Infectives Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Vaginal Anti Infectives Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Oral
Table 4. Major Players of Ointment
Table 5. Global Vaginal Anti Infectives Sales by Type (2017-2022) & (K Units)
Table 6. Global Vaginal Anti Infectives Sales Market Share by Type (2017-2022)
Table 7. Global Vaginal Anti Infectives Revenue by Type (2017-2022) & ($ million)
Table 8. Global Vaginal Anti Infectives Revenue Market Share by Type (2017-2022)
Table 9. Global Vaginal Anti Infectives Sale Price by Type (2017-2022) & (US$/Unit)
Table 10. Global Vaginal Anti Infectives Sales by Application (2017-2022) & (K Units)
Table 11. Global Vaginal Anti Infectives Sales Market Share by Application (2017-2022)
Table 12. Global Vaginal Anti Infectives Revenue by Application (2017-2022)
Table 13. Global Vaginal Anti Infectives Revenue Market Share by Application (2017-2022)
Table 14. Global Vaginal Anti Infectives Sale Price by Application (2017-2022) & (US$/Unit)
Table 15. Global Vaginal Anti Infectives Sales by Company (2020-2022) & (K Units)
Table 16. Global Vaginal Anti Infectives Sales Market Share by Company (2020-2022)
Table 17. Global Vaginal Anti Infectives Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Vaginal Anti Infectives Revenue Market Share by Company (2020-2022)
Table 19. Global Vaginal Anti Infectives Sale Price by Company (2020-2022) & (US$/Unit)
Table 20. Key Manufacturers Vaginal Anti Infectives Producing Area Distribution and Sales Area
Table 21. Players Vaginal Anti Infectives Products Offered
Table 22. Vaginal Anti Infectives Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Vaginal Anti Infectives Sales by Geographic Region (2017-2022) & (K Units)
Table 26. Global Vaginal Anti Infectives Sales Market Share Geographic Region (2017-2022)
Table 27. Global Vaginal Anti Infectives Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Vaginal Anti Infectives Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Vaginal Anti Infectives Sales by Country/Region (2017-2022) & (K Units)
Table 30. Global Vaginal Anti Infectives Sales Market Share by Country/Region (2017-2022)
Table 31. Global Vaginal Anti Infectives Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Vaginal Anti Infectives Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Vaginal Anti Infectives Sales by Country (2017-2022) & (K Units)
Table 34. Americas Vaginal Anti Infectives Sales Market Share by Country (2017-2022)
Table 35. Americas Vaginal Anti Infectives Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Vaginal Anti Infectives Revenue Market Share by Country (2017-2022)
Table 37. Americas Vaginal Anti Infectives Sales by Type (2017-2022) & (K Units)
Table 38. Americas Vaginal Anti Infectives Sales Market Share by Type (2017-2022)
Table 39. Americas Vaginal Anti Infectives Sales by Application (2017-2022) & (K Units)
Table 40. Americas Vaginal Anti Infectives Sales Market Share by Application (2017-2022)
Table 41. APAC Vaginal Anti Infectives Sales by Region (2017-2022) & (K Units)
Table 42. APAC Vaginal Anti Infectives Sales Market Share by Region (2017-2022)
Table 43. APAC Vaginal Anti Infectives Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Vaginal Anti Infectives Revenue Market Share by Region (2017-2022)
Table 45. APAC Vaginal Anti Infectives Sales by Type (2017-2022) & (K Units)
Table 46. APAC Vaginal Anti Infectives Sales Market Share by Type (2017-2022)
Table 47. APAC Vaginal Anti Infectives Sales by Application (2017-2022) & (K Units)
Table 48. APAC Vaginal Anti Infectives Sales Market Share by Application (2017-2022)
Table 49. Europe Vaginal Anti Infectives Sales by Country (2017-2022) & (K Units)
Table 50. Europe Vaginal Anti Infectives Sales Market Share by Country (2017-2022)
Table 51. Europe Vaginal Anti Infectives Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Vaginal Anti Infectives Revenue Market Share by Country (2017-2022)
Table 53. Europe Vaginal Anti Infectives Sales by Type (2017-2022) & (K Units)
Table 54. Europe Vaginal Anti Infectives Sales Market Share by Type (2017-2022)
Table 55. Europe Vaginal Anti Infectives Sales by Application (2017-2022) & (K Units)
Table 56. Europe Vaginal Anti Infectives Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Vaginal Anti Infectives Sales by Country (2017-2022) & (K Units)
Table 58. Middle East & Africa Vaginal Anti Infectives Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Vaginal Anti Infectives Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Vaginal Anti Infectives Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Vaginal Anti Infectives Sales by Type (2017-2022) & (K Units)
Table 62. Middle East & Africa Vaginal Anti Infectives Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Vaginal Anti Infectives Sales by Application (2017-2022) & (K Units)
Table 64. Middle East & Africa Vaginal Anti Infectives Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Vaginal Anti Infectives
Table 66. Key Market Challenges & Risks of Vaginal Anti Infectives
Table 67. Key Industry Trends of Vaginal Anti Infectives
Table 68. Vaginal Anti Infectives Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Vaginal Anti Infectives Distributors List
Table 71. Vaginal Anti Infectives Customer List
Table 72. Global Vaginal Anti Infectives Sales Forecast by Region (2023-2028) & (K Units)
Table 73. Global Vaginal Anti Infectives Sales Market Forecast by Region
Table 74. Global Vaginal Anti Infectives Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Vaginal Anti Infectives Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Vaginal Anti Infectives Sales Forecast by Country (2023-2028) & (K Units)
Table 77. Americas Vaginal Anti Infectives Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Vaginal Anti Infectives Sales Forecast by Region (2023-2028) & (K Units)
Table 79. APAC Vaginal Anti Infectives Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Vaginal Anti Infectives Sales Forecast by Country (2023-2028) & (K Units)
Table 81. Europe Vaginal Anti Infectives Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Vaginal Anti Infectives Sales Forecast by Country (2023-2028) & (K Units)
Table 83. Middle East & Africa Vaginal Anti Infectives Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Vaginal Anti Infectives Sales Forecast by Type (2023-2028) & (K Units)
Table 85. Global Vaginal Anti Infectives Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Vaginal Anti Infectives Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Vaginal Anti Infectives Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Vaginal Anti Infectives Sales Forecast by Application (2023-2028) & (K Units)
Table 89. Global Vaginal Anti Infectives Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Vaginal Anti Infectives Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Vaginal Anti Infectives Revenue Market Share Forecast by Application (2023-2028)
Table 92. Pfizer Inc Basic Information, Vaginal Anti Infectives Manufacturing Base, Sales Area and Its Competitors
Table 93. Pfizer Inc Vaginal Anti Infectives Product Offered
Table 94. Pfizer Inc Vaginal Anti Infectives Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 95. Pfizer Inc Main Business
Table 96. Pfizer Inc Latest Developments
Table 97. Mylan N.V Basic Information, Vaginal Anti Infectives Manufacturing Base, Sales Area and Its Competitors
Table 98. Mylan N.V Vaginal Anti Infectives Product Offered
Table 99. Mylan N.V Vaginal Anti Infectives Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 100. Mylan N.V Main Business
Table 101. Mylan N.V Latest Developments
Table 102. Novartis AG Basic Information, Vaginal Anti Infectives Manufacturing Base, Sales Area and Its Competitors
Table 103. Novartis AG Vaginal Anti Infectives Product Offered
Table 104. Novartis AG Vaginal Anti Infectives Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 105. Novartis AG Main Business
Table 106. Novartis AG Latest Developments
Table 107. Hikma Pharmaceuticals plc Basic Information, Vaginal Anti Infectives Manufacturing Base, Sales Area and Its Competitors
Table 108. Hikma Pharmaceuticals plc Vaginal Anti Infectives Product Offered
Table 109. Hikma Pharmaceuticals plc Vaginal Anti Infectives Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 110. Hikma Pharmaceuticals plc Main Business
Table 111. Hikma Pharmaceuticals plc Latest Developments
Table 112. Aurobindo Pharma Basic Information, Vaginal Anti Infectives Manufacturing Base, Sales Area and Its Competitors
Table 113. Aurobindo Pharma Vaginal Anti Infectives Product Offered
Table 114. Aurobindo Pharma Vaginal Anti Infectives Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 115. Aurobindo Pharma Main Business
Table 116. Aurobindo Pharma Latest Developments
Table 117. AbbVie Inc Basic Information, Vaginal Anti Infectives Manufacturing Base, Sales Area and Its Competitors
Table 118. AbbVie Inc Vaginal Anti Infectives Product Offered
Table 119. AbbVie Inc Vaginal Anti Infectives Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 120. AbbVie Inc Main Business
Table 121. AbbVie Inc Latest Developments
Table 122. Melinta Therapeutics, Inc Basic Information, Vaginal Anti Infectives Manufacturing Base, Sales Area and Its Competitors
Table 123. Melinta Therapeutics, Inc Vaginal Anti Infectives Product Offered
Table 124. Melinta Therapeutics, Inc Vaginal Anti Infectives Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 125. Melinta Therapeutics, Inc Main Business
Table 126. Melinta Therapeutics, Inc Latest Developments
Table 127. Bristol-Myers Squibb Company Basic Information, Vaginal Anti Infectives Manufacturing Base, Sales Area and Its Competitors
Table 128. Bristol-Myers Squibb Company Vaginal Anti Infectives Product Offered
Table 129. Bristol-Myers Squibb Company Vaginal Anti Infectives Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 130. Bristol-Myers Squibb Company Main Business
Table 131. Bristol-Myers Squibb Company Latest Developments
Table 132. GSK plc Basic Information, Vaginal Anti Infectives Manufacturing Base, Sales Area and Its Competitors
Table 133. GSK plc Vaginal Anti Infectives Product Offered
Table 134. GSK plc Vaginal Anti Infectives Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 135. GSK plc Main Business
Table 136. GSK plc Latest Developments
Table 137. Bayer AG Basic Information, Vaginal Anti Infectives Manufacturing Base, Sales Area and Its Competitors
Table 138. Bayer AG Vaginal Anti Infectives Product Offered
Table 139. Bayer AG Vaginal Anti Infectives Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 140. Bayer AG Main Business
Table 141. Bayer AG Latest Developments
Table 142. Lupin Basic Information, Vaginal Anti Infectives Manufacturing Base, Sales Area and Its Competitors
Table 143. Lupin Vaginal Anti Infectives Product Offered
Table 144. Lupin Vaginal Anti Infectives Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 145. Lupin Main Business
Table 146. Lupin Latest Developments
Table 147. Perrigo Company plc Basic Information, Vaginal Anti Infectives Manufacturing Base, Sales Area and Its Competitors
Table 148. Perrigo Company plc Vaginal Anti Infectives Product Offered
Table 149. Perrigo Company plc Vaginal Anti Infectives Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 150. Perrigo Company plc Main Business
Table 151. Perrigo Company plc Latest Developments
Table 1. Vaginal Anti Infectives Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Vaginal Anti Infectives Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Oral
Table 4. Major Players of Ointment
Table 5. Global Vaginal Anti Infectives Sales by Type (2017-2022) & (K Units)
Table 6. Global Vaginal Anti Infectives Sales Market Share by Type (2017-2022)
Table 7. Global Vaginal Anti Infectives Revenue by Type (2017-2022) & ($ million)
Table 8. Global Vaginal Anti Infectives Revenue Market Share by Type (2017-2022)
Table 9. Global Vaginal Anti Infectives Sale Price by Type (2017-2022) & (US$/Unit)
Table 10. Global Vaginal Anti Infectives Sales by Application (2017-2022) & (K Units)
Table 11. Global Vaginal Anti Infectives Sales Market Share by Application (2017-2022)
Table 12. Global Vaginal Anti Infectives Revenue by Application (2017-2022)
Table 13. Global Vaginal Anti Infectives Revenue Market Share by Application (2017-2022)
Table 14. Global Vaginal Anti Infectives Sale Price by Application (2017-2022) & (US$/Unit)
Table 15. Global Vaginal Anti Infectives Sales by Company (2020-2022) & (K Units)
Table 16. Global Vaginal Anti Infectives Sales Market Share by Company (2020-2022)
Table 17. Global Vaginal Anti Infectives Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Vaginal Anti Infectives Revenue Market Share by Company (2020-2022)
Table 19. Global Vaginal Anti Infectives Sale Price by Company (2020-2022) & (US$/Unit)
Table 20. Key Manufacturers Vaginal Anti Infectives Producing Area Distribution and Sales Area
Table 21. Players Vaginal Anti Infectives Products Offered
Table 22. Vaginal Anti Infectives Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Vaginal Anti Infectives Sales by Geographic Region (2017-2022) & (K Units)
Table 26. Global Vaginal Anti Infectives Sales Market Share Geographic Region (2017-2022)
Table 27. Global Vaginal Anti Infectives Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Vaginal Anti Infectives Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Vaginal Anti Infectives Sales by Country/Region (2017-2022) & (K Units)
Table 30. Global Vaginal Anti Infectives Sales Market Share by Country/Region (2017-2022)
Table 31. Global Vaginal Anti Infectives Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Vaginal Anti Infectives Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Vaginal Anti Infectives Sales by Country (2017-2022) & (K Units)
Table 34. Americas Vaginal Anti Infectives Sales Market Share by Country (2017-2022)
Table 35. Americas Vaginal Anti Infectives Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Vaginal Anti Infectives Revenue Market Share by Country (2017-2022)
Table 37. Americas Vaginal Anti Infectives Sales by Type (2017-2022) & (K Units)
Table 38. Americas Vaginal Anti Infectives Sales Market Share by Type (2017-2022)
Table 39. Americas Vaginal Anti Infectives Sales by Application (2017-2022) & (K Units)
Table 40. Americas Vaginal Anti Infectives Sales Market Share by Application (2017-2022)
Table 41. APAC Vaginal Anti Infectives Sales by Region (2017-2022) & (K Units)
Table 42. APAC Vaginal Anti Infectives Sales Market Share by Region (2017-2022)
Table 43. APAC Vaginal Anti Infectives Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Vaginal Anti Infectives Revenue Market Share by Region (2017-2022)
Table 45. APAC Vaginal Anti Infectives Sales by Type (2017-2022) & (K Units)
Table 46. APAC Vaginal Anti Infectives Sales Market Share by Type (2017-2022)
Table 47. APAC Vaginal Anti Infectives Sales by Application (2017-2022) & (K Units)
Table 48. APAC Vaginal Anti Infectives Sales Market Share by Application (2017-2022)
Table 49. Europe Vaginal Anti Infectives Sales by Country (2017-2022) & (K Units)
Table 50. Europe Vaginal Anti Infectives Sales Market Share by Country (2017-2022)
Table 51. Europe Vaginal Anti Infectives Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Vaginal Anti Infectives Revenue Market Share by Country (2017-2022)
Table 53. Europe Vaginal Anti Infectives Sales by Type (2017-2022) & (K Units)
Table 54. Europe Vaginal Anti Infectives Sales Market Share by Type (2017-2022)
Table 55. Europe Vaginal Anti Infectives Sales by Application (2017-2022) & (K Units)
Table 56. Europe Vaginal Anti Infectives Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Vaginal Anti Infectives Sales by Country (2017-2022) & (K Units)
Table 58. Middle East & Africa Vaginal Anti Infectives Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Vaginal Anti Infectives Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Vaginal Anti Infectives Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Vaginal Anti Infectives Sales by Type (2017-2022) & (K Units)
Table 62. Middle East & Africa Vaginal Anti Infectives Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Vaginal Anti Infectives Sales by Application (2017-2022) & (K Units)
Table 64. Middle East & Africa Vaginal Anti Infectives Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Vaginal Anti Infectives
Table 66. Key Market Challenges & Risks of Vaginal Anti Infectives
Table 67. Key Industry Trends of Vaginal Anti Infectives
Table 68. Vaginal Anti Infectives Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Vaginal Anti Infectives Distributors List
Table 71. Vaginal Anti Infectives Customer List
Table 72. Global Vaginal Anti Infectives Sales Forecast by Region (2023-2028) & (K Units)
Table 73. Global Vaginal Anti Infectives Sales Market Forecast by Region
Table 74. Global Vaginal Anti Infectives Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Vaginal Anti Infectives Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Vaginal Anti Infectives Sales Forecast by Country (2023-2028) & (K Units)
Table 77. Americas Vaginal Anti Infectives Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Vaginal Anti Infectives Sales Forecast by Region (2023-2028) & (K Units)
Table 79. APAC Vaginal Anti Infectives Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Vaginal Anti Infectives Sales Forecast by Country (2023-2028) & (K Units)
Table 81. Europe Vaginal Anti Infectives Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Vaginal Anti Infectives Sales Forecast by Country (2023-2028) & (K Units)
Table 83. Middle East & Africa Vaginal Anti Infectives Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Vaginal Anti Infectives Sales Forecast by Type (2023-2028) & (K Units)
Table 85. Global Vaginal Anti Infectives Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Vaginal Anti Infectives Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Vaginal Anti Infectives Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Vaginal Anti Infectives Sales Forecast by Application (2023-2028) & (K Units)
Table 89. Global Vaginal Anti Infectives Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Vaginal Anti Infectives Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Vaginal Anti Infectives Revenue Market Share Forecast by Application (2023-2028)
Table 92. Pfizer Inc Basic Information, Vaginal Anti Infectives Manufacturing Base, Sales Area and Its Competitors
Table 93. Pfizer Inc Vaginal Anti Infectives Product Offered
Table 94. Pfizer Inc Vaginal Anti Infectives Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 95. Pfizer Inc Main Business
Table 96. Pfizer Inc Latest Developments
Table 97. Mylan N.V Basic Information, Vaginal Anti Infectives Manufacturing Base, Sales Area and Its Competitors
Table 98. Mylan N.V Vaginal Anti Infectives Product Offered
Table 99. Mylan N.V Vaginal Anti Infectives Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 100. Mylan N.V Main Business
Table 101. Mylan N.V Latest Developments
Table 102. Novartis AG Basic Information, Vaginal Anti Infectives Manufacturing Base, Sales Area and Its Competitors
Table 103. Novartis AG Vaginal Anti Infectives Product Offered
Table 104. Novartis AG Vaginal Anti Infectives Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 105. Novartis AG Main Business
Table 106. Novartis AG Latest Developments
Table 107. Hikma Pharmaceuticals plc Basic Information, Vaginal Anti Infectives Manufacturing Base, Sales Area and Its Competitors
Table 108. Hikma Pharmaceuticals plc Vaginal Anti Infectives Product Offered
Table 109. Hikma Pharmaceuticals plc Vaginal Anti Infectives Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 110. Hikma Pharmaceuticals plc Main Business
Table 111. Hikma Pharmaceuticals plc Latest Developments
Table 112. Aurobindo Pharma Basic Information, Vaginal Anti Infectives Manufacturing Base, Sales Area and Its Competitors
Table 113. Aurobindo Pharma Vaginal Anti Infectives Product Offered
Table 114. Aurobindo Pharma Vaginal Anti Infectives Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 115. Aurobindo Pharma Main Business
Table 116. Aurobindo Pharma Latest Developments
Table 117. AbbVie Inc Basic Information, Vaginal Anti Infectives Manufacturing Base, Sales Area and Its Competitors
Table 118. AbbVie Inc Vaginal Anti Infectives Product Offered
Table 119. AbbVie Inc Vaginal Anti Infectives Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 120. AbbVie Inc Main Business
Table 121. AbbVie Inc Latest Developments
Table 122. Melinta Therapeutics, Inc Basic Information, Vaginal Anti Infectives Manufacturing Base, Sales Area and Its Competitors
Table 123. Melinta Therapeutics, Inc Vaginal Anti Infectives Product Offered
Table 124. Melinta Therapeutics, Inc Vaginal Anti Infectives Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 125. Melinta Therapeutics, Inc Main Business
Table 126. Melinta Therapeutics, Inc Latest Developments
Table 127. Bristol-Myers Squibb Company Basic Information, Vaginal Anti Infectives Manufacturing Base, Sales Area and Its Competitors
Table 128. Bristol-Myers Squibb Company Vaginal Anti Infectives Product Offered
Table 129. Bristol-Myers Squibb Company Vaginal Anti Infectives Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 130. Bristol-Myers Squibb Company Main Business
Table 131. Bristol-Myers Squibb Company Latest Developments
Table 132. GSK plc Basic Information, Vaginal Anti Infectives Manufacturing Base, Sales Area and Its Competitors
Table 133. GSK plc Vaginal Anti Infectives Product Offered
Table 134. GSK plc Vaginal Anti Infectives Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 135. GSK plc Main Business
Table 136. GSK plc Latest Developments
Table 137. Bayer AG Basic Information, Vaginal Anti Infectives Manufacturing Base, Sales Area and Its Competitors
Table 138. Bayer AG Vaginal Anti Infectives Product Offered
Table 139. Bayer AG Vaginal Anti Infectives Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 140. Bayer AG Main Business
Table 141. Bayer AG Latest Developments
Table 142. Lupin Basic Information, Vaginal Anti Infectives Manufacturing Base, Sales Area and Its Competitors
Table 143. Lupin Vaginal Anti Infectives Product Offered
Table 144. Lupin Vaginal Anti Infectives Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 145. Lupin Main Business
Table 146. Lupin Latest Developments
Table 147. Perrigo Company plc Basic Information, Vaginal Anti Infectives Manufacturing Base, Sales Area and Its Competitors
Table 148. Perrigo Company plc Vaginal Anti Infectives Product Offered
Table 149. Perrigo Company plc Vaginal Anti Infectives Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 150. Perrigo Company plc Main Business
Table 151. Perrigo Company plc Latest Developments
LIST OF FIGURES
Figure 1. Picture of Vaginal Anti Infectives
Figure 2. Vaginal Anti Infectives Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Vaginal Anti Infectives Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Vaginal Anti Infectives Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Vaginal Anti Infectives Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Oral
Figure 10. Product Picture of Ointment
Figure 11. Global Vaginal Anti Infectives Sales Market Share by Type in 2021
Figure 12. Global Vaginal Anti Infectives Revenue Market Share by Type (2017-2022)
Figure 13. Vaginal Anti Infectives Consumed in Bacterial Vaginitis
Figure 14. Global Vaginal Anti Infectives Market: Bacterial Vaginitis (2017-2022) & (K Units)
Figure 15. Vaginal Anti Infectives Consumed in Trichomonal Vaginitis
Figure 16. Global Vaginal Anti Infectives Market: Trichomonal Vaginitis (2017-2022) & (K Units)
Figure 17. Vaginal Anti Infectives Consumed in Candida Vaginitis
Figure 18. Global Vaginal Anti Infectives Market: Candida Vaginitis (2017-2022) & (K Units)
Figure 19. Global Vaginal Anti Infectives Sales Market Share by Application (2017-2022)
Figure 20. Global Vaginal Anti Infectives Revenue Market Share by Application in 2021
Figure 21. Vaginal Anti Infectives Revenue Market by Company in 2021 ($ Million)
Figure 22. Global Vaginal Anti Infectives Revenue Market Share by Company in 2021
Figure 23. Global Vaginal Anti Infectives Sales Market Share by Geographic Region (2017-2022)
Figure 24. Global Vaginal Anti Infectives Revenue Market Share by Geographic Region in 2021
Figure 25. Global Vaginal Anti Infectives Sales Market Share by Region (2017-2022)
Figure 26. Global Vaginal Anti Infectives Revenue Market Share by Country/Region in 2021
Figure 27. Americas Vaginal Anti Infectives Sales 2017-2022 (K Units)
Figure 28. Americas Vaginal Anti Infectives Revenue 2017-2022 ($ Millions)
Figure 29. APAC Vaginal Anti Infectives Sales 2017-2022 (K Units)
Figure 30. APAC Vaginal Anti Infectives Revenue 2017-2022 ($ Millions)
Figure 31. Europe Vaginal Anti Infectives Sales 2017-2022 (K Units)
Figure 32. Europe Vaginal Anti Infectives Revenue 2017-2022 ($ Millions)
Figure 33. Middle East & Africa Vaginal Anti Infectives Sales 2017-2022 (K Units)
Figure 34. Middle East & Africa Vaginal Anti Infectives Revenue 2017-2022 ($ Millions)
Figure 35. Americas Vaginal Anti Infectives Sales Market Share by Country in 2021
Figure 36. Americas Vaginal Anti Infectives Revenue Market Share by Country in 2021
Figure 37. United States Vaginal Anti Infectives Revenue Growth 2017-2022 ($ Millions)
Figure 38. Canada Vaginal Anti Infectives Revenue Growth 2017-2022 ($ Millions)
Figure 39. Mexico Vaginal Anti Infectives Revenue Growth 2017-2022 ($ Millions)
Figure 40. Brazil Vaginal Anti Infectives Revenue Growth 2017-2022 ($ Millions)
Figure 41. APAC Vaginal Anti Infectives Sales Market Share by Region in 2021
Figure 42. APAC Vaginal Anti Infectives Revenue Market Share by Regions in 2021
Figure 43. China Vaginal Anti Infectives Revenue Growth 2017-2022 ($ Millions)
Figure 44. Japan Vaginal Anti Infectives Revenue Growth 2017-2022 ($ Millions)
Figure 45. South Korea Vaginal Anti Infectives Revenue Growth 2017-2022 ($ Millions)
Figure 46. Southeast Asia Vaginal Anti Infectives Revenue Growth 2017-2022 ($ Millions)
Figure 47. India Vaginal Anti Infectives Revenue Growth 2017-2022 ($ Millions)
Figure 48. Australia Vaginal Anti Infectives Revenue Growth 2017-2022 ($ Millions)
Figure 49. Europe Vaginal Anti Infectives Sales Market Share by Country in 2021
Figure 50. Europe Vaginal Anti Infectives Revenue Market Share by Country in 2021
Figure 51. Germany Vaginal Anti Infectives Revenue Growth 2017-2022 ($ Millions)
Figure 52. France Vaginal Anti Infectives Revenue Growth 2017-2022 ($ Millions)
Figure 53. UK Vaginal Anti Infectives Revenue Growth 2017-2022 ($ Millions)
Figure 54. Italy Vaginal Anti Infectives Revenue Growth 2017-2022 ($ Millions)
Figure 55. Russia Vaginal Anti Infectives Revenue Growth 2017-2022 ($ Millions)
Figure 56. Middle East & Africa Vaginal Anti Infectives Sales Market Share by Country in 2021
Figure 57. Middle East & Africa Vaginal Anti Infectives Revenue Market Share by Country in 2021
Figure 58. Egypt Vaginal Anti Infectives Revenue Growth 2017-2022 ($ Millions)
Figure 59. South Africa Vaginal Anti Infectives Revenue Growth 2017-2022 ($ Millions)
Figure 60. Israel Vaginal Anti Infectives Revenue Growth 2017-2022 ($ Millions)
Figure 61. Turkey Vaginal Anti Infectives Revenue Growth 2017-2022 ($ Millions)
Figure 62. GCC Country Vaginal Anti Infectives Revenue Growth 2017-2022 ($ Millions)
Figure 63. Manufacturing Cost Structure Analysis of Vaginal Anti Infectives in 2021
Figure 64. Manufacturing Process Analysis of Vaginal Anti Infectives
Figure 65. Industry Chain Structure of Vaginal Anti Infectives
Figure 66. Channels of Distribution
Figure 67. Distributors Profiles
Figure 1. Picture of Vaginal Anti Infectives
Figure 2. Vaginal Anti Infectives Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Vaginal Anti Infectives Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Vaginal Anti Infectives Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Vaginal Anti Infectives Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Oral
Figure 10. Product Picture of Ointment
Figure 11. Global Vaginal Anti Infectives Sales Market Share by Type in 2021
Figure 12. Global Vaginal Anti Infectives Revenue Market Share by Type (2017-2022)
Figure 13. Vaginal Anti Infectives Consumed in Bacterial Vaginitis
Figure 14. Global Vaginal Anti Infectives Market: Bacterial Vaginitis (2017-2022) & (K Units)
Figure 15. Vaginal Anti Infectives Consumed in Trichomonal Vaginitis
Figure 16. Global Vaginal Anti Infectives Market: Trichomonal Vaginitis (2017-2022) & (K Units)
Figure 17. Vaginal Anti Infectives Consumed in Candida Vaginitis
Figure 18. Global Vaginal Anti Infectives Market: Candida Vaginitis (2017-2022) & (K Units)
Figure 19. Global Vaginal Anti Infectives Sales Market Share by Application (2017-2022)
Figure 20. Global Vaginal Anti Infectives Revenue Market Share by Application in 2021
Figure 21. Vaginal Anti Infectives Revenue Market by Company in 2021 ($ Million)
Figure 22. Global Vaginal Anti Infectives Revenue Market Share by Company in 2021
Figure 23. Global Vaginal Anti Infectives Sales Market Share by Geographic Region (2017-2022)
Figure 24. Global Vaginal Anti Infectives Revenue Market Share by Geographic Region in 2021
Figure 25. Global Vaginal Anti Infectives Sales Market Share by Region (2017-2022)
Figure 26. Global Vaginal Anti Infectives Revenue Market Share by Country/Region in 2021
Figure 27. Americas Vaginal Anti Infectives Sales 2017-2022 (K Units)
Figure 28. Americas Vaginal Anti Infectives Revenue 2017-2022 ($ Millions)
Figure 29. APAC Vaginal Anti Infectives Sales 2017-2022 (K Units)
Figure 30. APAC Vaginal Anti Infectives Revenue 2017-2022 ($ Millions)
Figure 31. Europe Vaginal Anti Infectives Sales 2017-2022 (K Units)
Figure 32. Europe Vaginal Anti Infectives Revenue 2017-2022 ($ Millions)
Figure 33. Middle East & Africa Vaginal Anti Infectives Sales 2017-2022 (K Units)
Figure 34. Middle East & Africa Vaginal Anti Infectives Revenue 2017-2022 ($ Millions)
Figure 35. Americas Vaginal Anti Infectives Sales Market Share by Country in 2021
Figure 36. Americas Vaginal Anti Infectives Revenue Market Share by Country in 2021
Figure 37. United States Vaginal Anti Infectives Revenue Growth 2017-2022 ($ Millions)
Figure 38. Canada Vaginal Anti Infectives Revenue Growth 2017-2022 ($ Millions)
Figure 39. Mexico Vaginal Anti Infectives Revenue Growth 2017-2022 ($ Millions)
Figure 40. Brazil Vaginal Anti Infectives Revenue Growth 2017-2022 ($ Millions)
Figure 41. APAC Vaginal Anti Infectives Sales Market Share by Region in 2021
Figure 42. APAC Vaginal Anti Infectives Revenue Market Share by Regions in 2021
Figure 43. China Vaginal Anti Infectives Revenue Growth 2017-2022 ($ Millions)
Figure 44. Japan Vaginal Anti Infectives Revenue Growth 2017-2022 ($ Millions)
Figure 45. South Korea Vaginal Anti Infectives Revenue Growth 2017-2022 ($ Millions)
Figure 46. Southeast Asia Vaginal Anti Infectives Revenue Growth 2017-2022 ($ Millions)
Figure 47. India Vaginal Anti Infectives Revenue Growth 2017-2022 ($ Millions)
Figure 48. Australia Vaginal Anti Infectives Revenue Growth 2017-2022 ($ Millions)
Figure 49. Europe Vaginal Anti Infectives Sales Market Share by Country in 2021
Figure 50. Europe Vaginal Anti Infectives Revenue Market Share by Country in 2021
Figure 51. Germany Vaginal Anti Infectives Revenue Growth 2017-2022 ($ Millions)
Figure 52. France Vaginal Anti Infectives Revenue Growth 2017-2022 ($ Millions)
Figure 53. UK Vaginal Anti Infectives Revenue Growth 2017-2022 ($ Millions)
Figure 54. Italy Vaginal Anti Infectives Revenue Growth 2017-2022 ($ Millions)
Figure 55. Russia Vaginal Anti Infectives Revenue Growth 2017-2022 ($ Millions)
Figure 56. Middle East & Africa Vaginal Anti Infectives Sales Market Share by Country in 2021
Figure 57. Middle East & Africa Vaginal Anti Infectives Revenue Market Share by Country in 2021
Figure 58. Egypt Vaginal Anti Infectives Revenue Growth 2017-2022 ($ Millions)
Figure 59. South Africa Vaginal Anti Infectives Revenue Growth 2017-2022 ($ Millions)
Figure 60. Israel Vaginal Anti Infectives Revenue Growth 2017-2022 ($ Millions)
Figure 61. Turkey Vaginal Anti Infectives Revenue Growth 2017-2022 ($ Millions)
Figure 62. GCC Country Vaginal Anti Infectives Revenue Growth 2017-2022 ($ Millions)
Figure 63. Manufacturing Cost Structure Analysis of Vaginal Anti Infectives in 2021
Figure 64. Manufacturing Process Analysis of Vaginal Anti Infectives
Figure 65. Industry Chain Structure of Vaginal Anti Infectives
Figure 66. Channels of Distribution
Figure 67. Distributors Profiles
